skip to primary navigationskip to content

Nobel-winning drug 'tackles malaria'.

last modified Oct 28, 2015 10:11 AM
Early data coming out of trials of ivermectin in Burkina Faso suggest it leads to 16% fewer cases of childhood malaria.

Scientists at the American Society of Tropical Medicine and Hygiene's conference, said the drug was toxic to blood-drinking mosquitoes.

They said their findings were pretty exciting, but still at an early stage.

Ivermectin is already used to kill parasitic worms, which affect a third of the world's population and cause illnesses including river blindness and lymphatic filariasis.

Its discovery won this year's Nobel Prize for Physiology or Medicine.

More can be read on the BBC health website http://www.bbc.co.uk/news/health-34649016

Upcoming events

Immunogenomics of Disease: Accelerating to Patient Benefit

Feb 05, 2019

Wellcome Genome Campus, UK

Upcoming events

The new Capella building- CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Capella building will be finished in 2018.

Fibroblast

‘Fibroblast’ has been developed from a conversation between Harold Offeh and Dr Alice Denton, a scientist based at the Babraham Institute and a member of the Cambridge Immunology Network. Offeh was particularly interested in the character and roles played by particular cells in the immune system, as well as the immune system’s role as a primary source of protection and care. The film takes as a starting point microscopic images of broblast cells, an area of research for Dr Denton.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more